Positive total ADAbs, n (%) |
13 (35) |
21 (39) |
10
(21) |
Positive ADAbs anti IFX, n |
8 |
11 |
8 |
Positive ADAbs anti ADA, n |
5 |
10 |
2 |
Mean anti-IFX ADAbs rate (UI/ml) |
15.7 [0-200] |
60.5 [0-200] |
0.7 [0-200] |
Mean anti-ADA ADAbs rate (UI/ml) |
5.61 [0.64-111] |
6.5 [0-405] |
5.69 [0-405] |
Mean IFX residual dose rate (µg/ml) |
0.43 [0.23-3] |
0.54
[0-9.5] |
1.5 [0-5.67] |
Mean ADA residual dose rate (µg/ml) |
5.06 [0-8] |
5.9 [0-9.32] |
4.85 [0-7.85] |